When Continuing Tirzepatide Makes Sense For patients with type 2 diabetes, obesity-related conditions (sleep apnea, joint pain, hypertension), or a strong family history of weight regain, continuing tirzepatide long-term often delivers the most stable health outcomes
(Reuters) -Eli Lilly signed an agreement with Cipla, allowing the Indian drugmaker to sell its blockbuster weight-loss drug under a separate brand in the country, the companies said on Thursday
doi: 10.1161/CIRCRESAHA.115.306398 259 CoateKCHernandezGThorneCASunSLeTDVValeKet al
According to the American Association of Clinical Endocrinologists and American College of Endocrinology (AACE/ACE) Obesity Clinical Practice Guidelines, obese patients receiving incretin-based therapies for weight loss should be monitored for the development of pancreatitis
This can worsen symptoms of nausea and indigestion